The Generic Drug User Fee Amendment III public meeting agenda will include a keynote address by FDA Commissioner Stephen Hahn and presentations by FDA staff and stakeholder groups, as well as public comment.
Teva's ProAir Digihaler is the first and only digital rescue inhaler indicated in patients 4 years old and older for the treatment or prevention of bronchospasm who have reversible obstructive airway disease.